title: Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris.
abstract: The purpose of this trial was to assess whether the addition of hyperbaric oxygen to percutaneous coronary intervention can reduce clinical restenosis. Major adverse cardiac events at 8 months were found in only 1 of 24 patients (4%) who received hyperbaric oxygen compared with 13 of 37 patients (35%) who did not.
authors.affiliation: Department of Cardiology, St. Vincent Charity Hospital, Case Western Reserve University and the University Hospital of Cleveland, Ohio, USA. mohsen.sharifi@ttuhsc.edu
authors.forename: Mohsen
authors.initials: M
authors.lastname: Sharifi
authors.forename: Wassim
authors.initials: W
authors.lastname: Fares
authors.forename: Isam
authors.initials: I
authors.lastname: Abdel-Karim
authors.forename: J Michael
authors.initials: JM
authors.lastname: Koch
authors.forename: Joseph
authors.initials: J
authors.lastname: Sopko
authors.forename: Dale
authors.initials: D
authors.lastname: Adler
mesh_terms: D000368:Aged; D000789:Angina, Unstable / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D016896:Treatment Outcome